Compare LAMR & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAMR | RVTY |
|---|---|---|
| Founded | 1902 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 11.8B |
| IPO Year | 1999 | 1994 |
| Metric | LAMR | RVTY |
|---|---|---|
| Price | $130.23 | $84.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | ★ $136.00 | $113.00 |
| AVG Volume (30 Days) | 518.0K | ★ 1.0M |
| Earning Date | 05-07-2026 | 04-27-2026 |
| Dividend Yield | ★ 4.94% | 0.33% |
| EPS Growth | ★ 63.92 | N/A |
| EPS | ★ 5.77 | 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $6.47 | $6.34 |
| Revenue Next Year | $3.77 | $5.10 |
| P/E Ratio | ★ $22.70 | $41.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $99.84 | $81.36 |
| 52 Week High | $139.83 | $118.30 |
| Indicator | LAMR | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 36.04 | 29.72 |
| Support Level | $123.43 | $82.98 |
| Resistance Level | $134.97 | $94.75 |
| Average True Range (ATR) | 2.72 | 2.96 |
| MACD | -0.96 | -0.66 |
| Stochastic Oscillator | 6.01 | 2.04 |
Lamar Advertising Co is an outdoor advertising companies in the United States and operates as a Real Estate Investment Trust. It rent space for advertising on billboards, buses, shelters, benches, logo plates and in airport terminals and also offer customers a fully integrated service with all aspects of their display requirements from ad copy production to placement and maintenance. It has two operating segments: billboard and Others. Key revenue is generated from Billboard segment.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.